国际辅助生殖技术监测委员会世界报告:2019年辅助生殖技术
该报告基于各国及地区登记处提交的周期与妊娠结局数据,回顾性横断面调查2019年全球辅助生殖技术的应用、有效性与安全性。共报告3,544,683个周期、783,073名婴儿出生,自体和冻融胚胎移植及单胚胎移植比例上升,多胎分娩率下降。
要点
- 2019年报告周期数与婴儿数较2018年增加约8%。
- 自体冻融移植占无PGT自体移植的61.8%,全冻周期占38.4%。
- PGT周期占报告周期的6.6%,多胎分娩率在PGT周期为4.2%。
核心结论
- 该报告是当前最全面的全球ART应用、有效性与安全性总结,记录了报告周期与婴儿数增加、胚胎冷冻与单胚胎移植应用增长、PGT周期数增加及多胎分娩减少,并为2020年COVID-19大流行影响提供基准。
研究设计与样本
- 回顾性横断面调查,数据来自国家和区域登记处提交的周期与妊娠结局数据。
- 研究对象为接受ART程序的患者。
- 报告了3,544,683个周期和783,073名婴儿出生;报告国家包括未报告诊所的估计≥3,855,694个周期和>865,914名婴儿。
主要发现
- 报告周期数与婴儿数较2018年增加约8%。
- 自体冻融移植占所有无PGT自体移植的61.8%,高于2015年的14.8%。
- 报告国家中全冻周期占比2019年为38.4%,高于2015年的24.6%。
- 44个国家报告了233,833个启动的PGT周期,占报告周期的6.6%,而2015年为2.6%。
- 自体卵母细胞每穿刺的活产率为22.9%,每穿刺累积活产率为38.6%(排除PGT)。
关键数值与推荐
- 每次移植的活产率:自体新鲜移植31.3%,自体冻融移植31.9%,使用PGT移植48.7%,卵母细胞捐赠移植(合并新鲜与冻融)34.6%。
- 新鲜自体周期(排除PGT)平均移植胚胎数1.51,单胚胎移植比例55.6%,多胎分娩率17.7%。
- 自体冻融周期(排除PGT)平均移植胚胎数1.26,单胚胎移植比例74.1%,多胎分娩率13.0%。
- 卵母细胞捐赠(合并新鲜与冻融)多胎分娩率10.8%;使用PGT周期多胎分娩率4.2%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the utilization, effectiveness, and safety of assisted reproductive technologies (ARTs) in 2019. DESIGN: A retrospective, cross-sectional survey derived from cycle and pregnancy outcome data submitted by national and regional registries. SUBJECTS: Patients undergoing ART procedures. INTERVENTION: Assisted reproductive technology. MAIN OUTCOME MEASURES: Outcomes on country, regional, and global levels. RESULTS: There were 3,544,683 cycles with 783,073 infants born reported. There were an estimated ≥3,855,694 cycles with >865,914 infants in reporting countries including nonreporting clinics. The reported number of cycles and infants increased by approximately 8% from 2018. Autologous frozen-thawed transfers accounted for 61.8% of all autologous transfers without preimplantation genetic testing (PGT), up from 14.8% in 2015. Among all reporting countries, the percentage of freeze-all cycles was 38.4% in 2019, up from 24.6% in 2015. There were 233,833 initiated PGT cycles reported from 44 countries, representing 6.6% of reported cycles vs. 2.6% in 2015. The delivery rate for autologous oocytes was 22.9% per aspiration, with a cumulative delivery rate of 38.6% per aspiration (excluding PGT). Per transfer, the delivery rates were 31.3% for autologous fresh transfers, 31.9% for autologous frozen transfers, 48.7% for transfers using PGT, and 34.6% for transfers after oocyte donation (combined fresh and frozen transfers).In fresh autologous cycles (excluding PGT), the mean number of transferred embryos was 1.51, the proportion of single embryo transfers was 55.6%, and the multiple delivery rate was 17.7%. In autologous frozen-thawed cycles (excluding PGT), the mean number of transferred embryos was 1.26, the proportion of single embryo transfers was 74.1%, and the multiple delivery rate was 13.0%. With oocyte donation (combined fresh and frozen transfers), the multiple delivery rate was 10.8%. The multiple delivery rate for cycles using PGT was 4.2%. CONCLUSION: The International Committee for Monitoring Assisted Reproductive Technologies report is the most comprehensive summary of global ART utilization, effectiveness, and safety currently available. The report documents an increase in reported cycles and infants born from previous years, growing utilization of embryo cryopreservation and single embryo transfers, increasing numbers of PGT cycles, and a reduction in multiple deliveries. It also provides a benchmark for the impact of the coronavirus disease 2019 pandemic in 2020.
引用
- Dyer S, Chambers GM, Jwa SC, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2019. Fertil Steril. 2025. PMID: 40513636. doi:10.1016/j.fertnstert.2025.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。